Gayer Charles K 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Dec 16, 2025
Insider Transaction Report
Form 4
Gayer Charles K
President and CCO
Transactions
- Tax Payment
Common Stock
[F1]2025-12-12$7.57/sh−8,181$61,930→ 418,827 total
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted restricted stock units. This transaction does not represent a sale by the reporting person.
Signature
/s/ Alane P. Barnes, by power of attorney|2025-12-16